Comprehensive FDA reform has "20%-30% chance" of passing Congress -- House staffer.
This article was originally published in The Tan Sheet
COMPREHENSIVE FDA REFORM HAS SLIM CHANCE OF PASSING EITHER HOUSE IN 1996, House Government Reform/Intergovern-mental Relations Subcommittee Staff Director Lawrence Halloran predicted Feb. 26 at the ACIL Issues Forum in Washington, D.C. "I wouldn't give universal FDA reform better than a 20%-30% chance of passing one house in this Congress," Halloran said. The ACIL is an association of independent laboratories.
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC